Loading organizations...

§ Private Profile · London, England, United Kingdom
Venture capital firm providing capital for early-stage companies, focused on climate technology and sustainable innovation.
Emerald is a healthcare technology company that operates a preventive health membership platform providing patients with personalized medical screenings and diagnostic services. The organization focuses on early disease detection and proactive wellness management by offering comprehensive health assessments that integrate advanced imaging, extensive biomarker analysis, and genetic testing. Through its digital platform, the company connects its members with a network of specialized physicians and clinical facilities to facilitate routine monitoring and personalized care plans. By consolidating various diagnostic modalities into a single subscription service, the platform streamlines the patient experience and reduces the logistical friction traditionally associated with navigating the fragmented healthcare system. The enterprise primarily targets consumers seeking actionable insights into their long-term well-being and physiological baselines. Emerald was founded to modernize preventive medicine by shifting the clinical focus from reactive treatments toward proactive health optimization.
Emerald has raised $2.0M across 2 funding rounds.
Emerald has raised $2.0M in total across 2 funding rounds.
Emerald has raised $2.0M across 2 funding rounds. Most recently, it raised $1.2M Seed Extension in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 29, 2026 | $1.2M Seed Plus | Boost Capital Partners | Mark Fountain, Granatus Ventures | Announced |
| May 14, 2025 | $850K Venture Round | — | Harry Glorikian, Jane Austin, Johann 'hans' Huber, Mart Abramov, Mike B., Nikolay Tretiakov, Patrick Bamford | Announced |
Emerald has raised $2.0M in total across 2 funding rounds.
Emerald's investors include Boost Capital Partners, Mark Fountain, Granatus Ventures, Harry Glorikian, Jane Austin, Johann 'Hans' Huber, Mart Abramov, Mike B., Nikolay Tretiakov, Patrick Bamford.